Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Regeneron's ARCALYST meets primary, secondary endpoints in second Phase 3 gout flare study

Regeneron Pharmaceuticals, Inc. announced that in a second Phase 3 study (PRE-SURGE 2) in gout patients initiating allopurinol therapy, ARCALYST (rilonacept) met the primary and all secondary study endpoints. The primary endpoint was the number of gout flares per patient over the 16-week treatment period.

28 Feb 2011

Positive results from Trius torezolid Phase 1 lung study

Trius Therapeutics, Inc. today announced results from its Phase 1 clinical trial to evaluate the ability of torezolid to penetrate into the lung for potential use to treat lung infections. In this study a 200 mg dose of torezolid phosphate was administered orally once-daily for three days to healthy adult volunteers. The trial achieved its primary goal of establishing the steady-state plasma pharmacokinetics and distribution of active drug into epithelial lining fluid (ELF).

28 Feb 2011

Immunitor to present latest results from imm01 trial in tuberculosis patients at African conference

Immune Network Ltd. advises that Immunitor will present latest results from its imm01 clinical trial in tuberculosis patients in Abuja, Nigeria at the 18th Union TB and Lung Diseases Conference of the African Region, 2nd to 5th March, 2011.

28 Feb 2011

Authorities work to contain measles scare

Health authorities are trying to prevent an outbreak of measles after a woman carrying the transmissible infection travelled widely throughout the United States. The lady in question, 27, allegedly contracted the airborne virus in the United Kingdom and arrived in the United States last week, passing through three U.S. airports on her way to New Mexico, where she is believed to reside. She arrived at Washington Dulles International Airport on Tuesday, February 22, from London.

28 Feb 2011

Scripps Health offers genetic testing to patients with Hepatitis C

Scripps Health is one of the first health systems in the United States to offer genetic testing as part of its care for hepatitis C patients planning to undergo drug treatment.

28 Feb 2011

Dizziness, nausea and achiness are symptoms of heart attack in females

Dizziness, nausea and achiness – no, these are not symptoms of the flu but signs of a heart attack in females. While heart attacks affect both men and women, the symptoms of a heart attack are surprisingly different between the genders. Virginia Health Information (VHI) this week released its Cardiac Care Report which provides consumers information comparing heart healthcare in Virginia. This year's report reveals women undergoing open heart surgery continued a five year trend of higher than expected readmission rates.

25 Feb 2011

Most patients 'want to be listened, informed and considered by family doctor'

A study conducted at the University of Granada reveals that patients have greater expectations of their family doctor listening actively to them, keeping them informed and considering their opinions than in getting involved in decision making. For the purpose of this study, researchers took a sample of 360 patients aged 16-47 years, assisted at the Health Center Gran Capitán in Granada

25 Feb 2011

BioCryst receives HHS contract to complete peramivir Phase 3 study in patients with influenza

BioCryst Pharmaceuticals, Inc. announced that it has been awarded a $55.0 million contract modification by the U.S. Department of Health & Human Services intended to fund to completion the Phase 3 development of its neuraminidase inhibitor, intravenous peramivir, for the treatment of patients hospitalized with influenza.

25 Feb 2011

MedInformatix, University Radiology work together to implement Federal Government-certified technology

University Radiology Group, New Jersey's largest provider of subspecialty radiology and teleradiology services, is working with MedInformatix Inc. to implement Federal Government-certified technology that enables medical practices to achieve Stage 1 meaningful use goals and objectives under The American Recovery and Reinvestment Act for Health Information Technology.

25 Feb 2011

PolyMedix completes PMX-30063 Phase 1 exposure-escalation clinical study to treat Staph infections

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, today announced the successful completion of a Phase 1 exposure-escalation clinical study with its synthetic defensin-mimetic antibiotic, PMX-30063.

24 Feb 2011

Positive results from Vertex VX-770 Phase 3 STRIVE study in patients with CF

Vertex Pharmaceuticals Incorporated today announced positive results from the Phase 3 STRIVE study of VX-770, an oral medicine in development that targets the defective protein that causes cystic fibrosis.

24 Feb 2011

Scientists suggest that lateral habenula can be a prime locus of human depression

A team of neuroscientists at Cold Spring Harbor Laboratory, Brookhaven National Laboratory and UC San Diego has collected evidence suggesting that a previously overlooked portion of the brain could be a prime locus of human depression.

24 Feb 2011

Biomatrica announces strategic partnership agreement with In-Q-Tel

Biomatrica, Inc., a leader in room temperature biostability technology, today announced a strategic partnership agreement with In-Q-Tel. IQT is the independent, strategic investment firm that identifies innovative technology solutions to support the mission of the U.S. Intelligence Community.

24 Feb 2011

New vaccine offers hope against Hepatitis C

Immunology: Three percent of the world's population is currently infected by hepatitis C. The virus hides in the liver and can cause cirrhosis and liver cancer, and it's the most frequent cause of liver transplants in Denmark.

24 Feb 2011

Finally! A vaccine against Dengue

Scientists from Thailand have successfully produced the world’s first dengue hemorrhagic fever vaccine and will allow the private sector improve it for the effective treatment of patients. The Thailand Ministry of Science and Technology has introduced the world’s first live attenuated dengue hemorrhagic fever vaccine.

23 Feb 2011

Multi-national consortium develops new approaches to cure the flu

Pharmacelsus GmbH announces its participation in the 4 year multi-national research cooperation project “FLUCURE” supported by the European Union with the goal of developing novel, small molecule based therapeutics for respiratory diseases caused by influenza viruses. The consortium also joined Vironova AB and Beactica AB (Sweden), Pike Pharma GmbH (Switzerland) and university-based research groups from Italy, Germany, Bulgaria, Lithuania, and the Netherlands.

23 Feb 2011

Study results of NanoViricides anti-dengue drug candidates presented at NIH/NIAID sponsored conference

NanoViricides, Inc.announced today that Anil R. Diwan, PhD, President of the Company, gave a presentation on Friday, February 18th, that discussed the Company's anti-viral technology and more specifically, results from both in-vitro and in-vivo studies of its drug candidates against dengue virus infections that can potentially cause a fatal manifestation, viz. dengue hemorrhagic fever.

23 Feb 2011

Pharmacelsus participates in FLUCURE project to develop novel therapeutics against influenza

Pharmacelsus GmbH announces its participation in the 4 year multi-national research cooperation project "FLUCURE" supported by the European Union with the goal of developing novel, small molecule based therapeutics for respiratory diseases caused by influenza viruses.

23 Feb 2011

Scientists receive HHS grant to investigate DSC127 in treatment of skin injuries linked with radiation exposure

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that researchers who invented DSC127 have been awarded a $4.5 million, 16-month grant by the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority to investigate preclinically the use of DSC127 in the treatment of skin injuries associated with acute radiation exposure.

23 Feb 2011

New study: Cannabis ingredient can improve appetites and sense of taste in cancer patients

The active ingredient in cannabis can improve the appetites and sense of taste in cancer patients, according to a new study published online in the cancer journal, Annals of Oncology today.

23 Feb 2011

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Regeneron's ARCALYST meets primary, secondary endpoints in second Phase 3 gout flare study

Positive results from Trius torezolid Phase 1 lung study

Immunitor to present latest results from imm01 trial in tuberculosis patients at African conference

Authorities work to contain measles scare

Scripps Health offers genetic testing to patients with Hepatitis C

Dizziness, nausea and achiness are symptoms of heart attack in females

Most patients 'want to be listened, informed and considered by family doctor'

BioCryst receives HHS contract to complete peramivir Phase 3 study in patients with influenza

MedInformatix, University Radiology work together to implement Federal Government-certified technology

PolyMedix completes PMX-30063 Phase 1 exposure-escalation clinical study to treat Staph infections

Positive results from Vertex VX-770 Phase 3 STRIVE study in patients with CF

Scientists suggest that lateral habenula can be a prime locus of human depression

Biomatrica announces strategic partnership agreement with In-Q-Tel

New vaccine offers hope against Hepatitis C

Finally! A vaccine against Dengue

Multi-national consortium develops new approaches to cure the flu

Study results of NanoViricides anti-dengue drug candidates presented at NIH/NIAID sponsored conference

Pharmacelsus participates in FLUCURE project to develop novel therapeutics against influenza

Scientists receive HHS grant to investigate DSC127 in treatment of skin injuries linked with radiation exposure

New study: Cannabis ingredient can improve appetites and sense of taste in cancer patients

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Newsletters you may be interested in